SAVIMS

SAVIMS logo white
Menu

Other scientific evidence

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

German Doctors and Lawyers Raise Concerns Over Covid Injections

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Wilson, R. (2021, August 31). German doctors and lawyers assess blood smears from people who have had Covid injections: “For me this is euthanasia. For me this is mass murder, a crime on a grand scale.” Expose News. https://expose-news.com/2021/08/31/german-doctors-and-lawyers-assess-blood-smears-from-people-who-have-had-covid-injections-for-me-this-is-euthanasia-for-me-this-is-mass-murder-a-crime-on-a-grand-scale Summary: The article discusses alarming findings from German doctors and lawyers regarding the blood of […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Risks of mRNA Vaccination in Adolescents: Myocarditis Concerns

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Høeg, T. B., Krug, A., Stevenson, J., & Mandrola, J. (2021). SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12-17: A stratified national database analysis. medRxiv. https://doi.org/10.1101/2021.08.30.21262866 Summary: This article investigates the incidence of myocarditis following mRNA COVID-19 vaccination in children aged 12-17, as reported through the Vaccine Adverse Event Reporting System (VAERS). It highlights

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Comparing SARS-CoV-2 Natural Immunity to Vaccine-Induced Immunity

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., & Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv. https://doi.org/10.1101/2021.08.24.21262415 Summary: This study compares the long-term protection provided by natural immunity from previous SARS-CoV-2 infection to that from the

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Kinetics of Antibody Decay After BNT162b2 Vaccination vs. SARS-CoV-2 Infection

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Israel, A., Shenhar, Y., Green, I., Merzon, E., Golan-Cohen, A., Schäffer, A. A., Ruppin, E., Magen, E., & Vinker, S. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. medRxiv. https://doi.org/10.1101/2021.08.03.21261496 Summary: This study investigates the decay of SARS-CoV-2 IgG antibodies in individuals vaccinated with two doses of

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SAHPRAs Monitoring of COVID-19 Vaccine Adverse Events

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: South African Health Products Regulatory Authority. (2021, August 20). SAHPRA statement on adverse events following immunisation (AEFIs) with COVID-19 vaccines. Summary: The South African Health Products Regulatory Authority (SAHPRA) oversees the safety of COVID-19 vaccines in collaboration with the National Department of Health (NDoH). Since the national vaccination roll-out commenced on 17 May 2021,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reduced Reinfection Risk with Vaccination in Previously Infected Individuals

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination – Kentucky, May–June 2021. Morbidity and Mortality Weekly Report, 70(32), 1081-1083. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7032e1-H.pdf Summary: A study conducted in Kentucky investigated the impact of COVID-19 vaccination on reinfection rates among individuals previously infected

COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Rising Hospitalisations Among Vaccinated Individuals in Israel

| | COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, August 11). 95% of severe patients in Israeli hospitals are vaccinated, warns doctor. Natural News. https://www.naturalnews.com/2021-08-11-95-severe-patients-israeli-hospitals-are-vaccinated.html Summary: Dr. Kobi Haviv reports a troubling trend in Israel, where 95% of severe COVID-19 patients in hospitals are vaccinated. Despite over 78% vaccination coverage, Israel has experienced a rise in serious cases. The

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Shedding of Infectious SARS-CoV-2 Despite Vaccination

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Riemersma, K. K., Haddock, L. A. III, Wilson, N. A., Minor, N., Eickhoff, J., Grogan, B. E., Kita-Yarbro, A., Halfmann, P. J., Segaloff, H. E., Kocharian, A., Florek, K. R., Westergaard, R., Bateman, A., Jeppson, G. E., Kawaoka, Y., O’Connor, D. H., Friedrich, T. C., & Grande, K. M. (2022). Shedding of infectious SARS-CoV-2

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Ivermectin for COVID-19: Evidence Review

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: South African National Department of Health. (2021). Rapid review of Ivermectin for COVID-19: Evidence review of clinical benefits and harms (Update: 30 July 2021). Summary: The South African National Department of Health conducted a rapid review to assess the efficacy of ivermectin in treating COVID-19. The review, which synthesised findings from multiple randomised controlled

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

A database of all Ivermectin studies for treatment of COVID-19

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Search results obtained to compile a database of all the studies done on Ivermecting as therapeutic drug for COVID-19. 2021-07-18. Summary: Database of all Ivermectin COVID-19 studies. 101 studies, 66 peer reviewed, 60 with results comparing treatment and control groups. DOWNLOAD

Scroll to Top